× Business
TelecomHealthcareDigital MarketingERPRetailMedia and EntertainmentOil and GasFood and BeveragesMarketing and AdvertisingBanking and Insurance
Technology
Big DataCloudIT ServiceSoftwareMobileSecurityNetworkingStorageCyber SecuritySAPData AnalysisloTBio Tech
Platform
Cisco DATABASE Google IBM Juniper Microsoft M2M Oracle Red hat Saas SYMANTEC
Leadership
CEO ReviewCMO ReviewCFO ReviewCompany Review
Magazines
US INDIA ASIA ARCHIVE
Startups Opinion Yearbook Readers Speak Contact Us

BIO TECH 

FEATURED

Gilead Sciences acquires Kite Pharma Inc.

Gilead Sciences Inc. acquired the Santa Monica biotech company Kite Pharma Inc. in a $11.9 billion deal. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, d...  Read More

siliconreview-gilead-sciences-acquires-kite-pharma-inc-

TRENDING


NEWS

siliconreview-gilead-sciences-acquires-kite-pharma-inc-

Gilead Sciences acquires Kite Pharma Inc.

Gilead Sciences Inc. acquired the Santa Monica biotech company Kite Pharma Inc. in a $11.9 billion deal. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused...   Read More

siliconreview-this-partnership-targets-to-implement-security-platform-across-growing-livestock-in-china

This partnership targets to implement security platform across growing livestock in China

Hongyang Biotechnology Co. Ltd is an animal health management and farm management provider sector in China which entered into a partnership with TruTag Technologies, Inc., a securi...   Read More

siliconreview-the-u-s--fda-has-approved-puma-biotechnologys-drug-for-her2-positive-breast-cancer

The U.S. FDA has approved Puma Biotechnology’s drug for HER2 positive breast cancer

Puma Biotechnology Inc’s NERLYNX (neratinib), formerly known as PB272, has been approved by the U.S. Food and Drug Administration for the treatment of breast cancer. As indic...   Read More

siliconreview-a-new-dna-delivery-technology-is-emerging-to-fight-against-drug-resistant-bacteria

A new DNA delivery technology is emerging to fight against drug-resistant bacteria

Tel Aviv University has relieved a new technology that facilitates DNA delivery into drug-resistant bacterial pathogens enabling their manipulation. The research expands the range ...   Read More

siliconreview-believe-it-or-not-nmr-spectroscopy-no-longer-requires-a-magnetic-field

Believe it or not NMR spectroscopy no longer requires a magnetic field!

The Nuclear Magnetic Resonance or often abbreviated as NMR is an ineludible word in the medicine and biology field. Until now the technology was limited to a large extent as it was...   Read More

siliconreview-scientists-look-upon-to-expunge-memories-that-provoke-anxiety

Scientists look upon to expunge memories that provoke anxiety

Findings of Columbia University Medical Center (CUMC) unveiled something unimaginable. And that jaw-dropping news is…. CUMC and McGill University suggest that there is a po...   Read More

siliconreview-bacteria-can-now-be-used-to-make-natural-colors-from-simple-sugar

Bacteria can now be used to make natural colors from simple sugar

Researchers at Rensselaer Polytechnic Institute have shown that four strains of E. coli bacteria working together can convert sugar into the natural red anthocyanin pigment found i...   Read More

siliconreview-pharma-mammoth-merck-sharp-dohme-msd-and-german-noxxon-pharma-begin-testing-immunoncologic-combo

Pharma mammoth Merck Sharp & Dohme (MSD) and German Noxxon Pharma begin testing immunoncologic combo

In the December of 2016, Berlin based Noxxon Pharma AG made a deal with Merck & Co. /MSD to assess the synergistic potential of NOXA1/2 and pembrolizumab immune cancer therapy....   Read More


YOU MIGHT ALSO LIKE::

ENROLL FOR UPCOMING ISSUE